SCM
UTMD icon

Sterling Capital Management’s Utah Medical Products UTMD Stock Holding History

Sterling Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.93K Sell
57
-43
-43% -$2.86K ﹤0.01% 2748
2026
Q1 		$6.2K Sell
100
-74
-43% -$4.66K ﹤0.01% 2626
2025
Q4 		$9.74K Sell
174
-37
-18% -$2.15K ﹤0.01% 2613
2025
Q3 		$13.3K Buy
211
+122
+137% +$7.22K ﹤0.01% 2341
2025
Q2 		$5.07K Buy
89
+35
+65% +$1.9K ﹤0.01% 2507
2025
Q1 		$3.03K Sell
54
-53
-50% -$3.17K ﹤0.01% 2409
2024
Q4 		$6.58K Buy
107
+96
+873% +$6.21K ﹤0.01% 2336
2024
Q3 		$736 Buy
+11
New +$747 ﹤0.01% 2692

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sterling Capital Management's UTMD Position: Q2 2026 in Review

Sterling Capital Management reduced its Utah Medical Products (UTMD) stake by 43% in Q2 2026, selling an estimated $2.86K and leaving 57 shares worth $3.93K. The position accounts for ﹤0.01% of the portfolio, ranked #2748.

Sterling Capital Management first reported a position in UTMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $13.3K in Q3 2025. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Sterling Capital Management held 57 shares of Utah Medical Products worth $3.93K as of Q2 2026.
  • Sterling Capital Management sold 43 Utah Medical Products shares in Q2 2026, an estimated $2.86K.
  • Utah Medical Products made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2748 holding.
  • Sterling Capital Management first reported a position in Utah Medical Products in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Utah Medical Products position peaked at $13.3K in Q3 2025.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.